Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-03-15 @ 5:58 AM
Study NCT ID:
NCT02598960
Status:
COMPLETED
Last Update Posted:
2023-03-06
First Post:
2015-10-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-16
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-21
First Submit QC Date:
None
Study First Post Date:
2015-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-12-15
Results First Submit QC Date:
None
Results First Post Date:
2023-03-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-12-21
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-02-03
Last Update Post Date:
2023-03-06
Last Update Post Date Type:
ACTUAL